On November 26, 2022, the donation signing ceremony of "Peking University Baheal Medical Science and Technology Innovation and Achievement Transformation Fund" was held at Peking University Health Science Center. Baheal Pharma Group donated a 10-year fund with a total amount of 20 million yuan to support the transformation of scientific research achievements in the medical field of Peking University. Qiao Jie, Executive Vice President and Director of Peking University, academician of the Chinese Academy of Engineering, Xiao Yuan and Wang Jiadong, Deputy Directors of Health Science Center, Geng Shu, Deputy Secretary General of Peking University Education Foundation of China, Fu Gang, Chairman of Baheal Pharma Group and Grade 1988 alumnus of Peking University Clinical Medicine Major, Song Qing, President of Baheal Pharma Group, Professor Wang Fan, Director of Peking University Medical Isotope Research Center, as well as heads of Academic Research Office , Estate Management Office/Technology Transfer Office of Peking University Health Science Center and heads of relevant departments of Baheal Pharma Group attended the donation ceremony.

Witnessed by the guests, Wang Jiadong, Geng Shu and Fu Gang signe the donation agreement.

With the rapid development of the medical and health industry and the growing diversified health needs of the people, the demand for high-level scientific research results and advanced treatment programs continues to increase, and the implementation of high-quality medical achievements into the true clinical application scenarios are urgently needed. In this process, it is of great significance for the high-quality development of the medical and health industry to improve the supporting measures for the transformation of scientific research achievements and accelerate industrialization and commercialization.

Qiao Jie presented the donation certificate to Fu Gang on behalf of Peking University Medical Center.

The donation of Baheal Pharma Group to the establishment of the "Peking University Baheal Medical Science and Technology Innovation and Achievement Transformation Fund" aims to explore scientific research projects with transformation potential in Peking University Medical Department and teaching hospitals through the establishment of a scientific and technological innovation evaluation system, and accelerate the industrialization of medical innovation achievements from laboratory and clinic so as to produce high-quality innovative achievements that can truly serve clinical needs and serve national health.

Qiao Jie delivers a speech.

At the ceremony, Qiao Jie, Executive Vice President of Peking University and Director of the Health Science Center of Peking University, expressed her sincere gratitude to Baheal Medical Group for its kindness and support for the development and construction of the Peking University Health Science Center, and presented the donation certificate to Baheal Medical Group on behalf of the Health Science Center of Peking University. She said that the rapid development of Peking University medical science in recent years could not be achieved without the support of alumni, who were always the most valuable resources and strength of Peking University Medical Science; moreover, the support of alumni was the motivation and spur of Peking University Medical Science, encouraging everyone to work harder and be more diligent. It is hoped that Peking University Medical University and Baheal Medical Group can work together for a win-win future and accelerate the transformation of scientific research results into "the last mile".

Fu Gang delivers a speech.

As a Grade 88 alumnus of Peking University Health Science Center, Fu Gang, chairman of Baheal Pharma Group, said in his speech that Baheal was an enterprise driven by scientific and technological innovation. The core founding team are all medical professionals. The pursuit of Baheal is to provide better medical and brand commercialization platform and services for the society. After more than ten years' development, Baheal has accumulated rich industrial resources in market research, manufacturing, clinical research resources, investment incubation and marketing, and formed a complete scientific research incubation system. It is hoped that based on these advantages, medical innovation resources can be revitalized, and high-quality scientific research results can be transformed continuously to benefit the people.

Teacher representatives presents flowers to Fu Gang

Guided by the national science and technology innovation strategy, Baheal Pharma Group has, in recent years, been actively exploring innovative development paths on the basis of continuously consolidating the capability of commercialization platform. Centering on the "ecological innovation" enterprise strategy, Baheal Pharma Group works closely with national scientific research institutions to promote the transformation of scientific research results and continuously incubate innovative results that can truly optimize the clinical medical scene. Currently, Baheal has established itself in three fields, namely innovative medicine, high-end medical equipment and technology transformation platform, to cultivate innovation projects, and has set up research achievements transformation bases and medical intelligent manufacturing industrialization bases in Beijing and Qingdao respectively so as to build a bridge for the transformation of scientific achievements to real productivity.

The donation ceremony

In the future, Baheal Pharma Group will give full play to the advantages of resource integration in the medical industry, focus on meeting clinical needs and making breakthroughs in key core technologies, accelerate innovation from the source, and jointly create new heights for the transformation of innovative achievements with national scientific research institutions.